MAPT and Alzheimer disease: Tau protein and β-amyloid peptide in pathologic conditions could have toxic effects on synapses leading to synaptic loss and/or dysfunction in AD (Zhou et al., 2017; for review, see Henstridge et al., 2016; Rajmohan and Reddy, 2017).